Abstract:Background Although high-throughput genotyping arrays have made whole-genome association studies (WGAS) feasible, only a small proportion of SNPs in the human genome are actually surveyed in such studies. In addition, various SNP arrays assay different sets of SNPs, which leads to challenges in comparing results and merging data for meta-analyses. Genome-wide imputation of untyped markers allows us to address these issues in a direct fashion. Methods 384 Caucasian American liver donors were genotyped using Illumina 650Y (Ilmn650Y) arrays, from which we also derived genotypes from the Ilmn317K array. On these data, we compared two imputation methods: MACH and BEAGLE. We imputed 2.5 million HapMap Release22 SNPs, and conducted GWAS on ~40,000 liver mRNA expression traits (eQTL analysis). In addition, 200 Caucasian American and 200 African American subjects were genotyped using the Affymetrix 500 K array plus a custom 164 K fill-in chip. We then imputed the HapMap SNPs and quantified the accuracy by randomly masking observed SNPs. Results MACH and BEAGLE perform similarly with respect to imputation accuracy. The Ilmn650Y results in excellent imputation performance, and it outperforms Affx500K or Ilmn317K sets. For Caucasian Americans, 90% of the HapMap SNPs were imputed at 98% accuracy. As expected, imputation of poorly tagged SNPs (untyped SNPs in weak LD with typed markers) was not as successful. It was more challenging to impute genotypes in the African American population, given (1) shorter LD blocks and (2) admixture with Caucasian populations in this population. To address issue (2), we pooled HapMap CEU and YRI data as an imputation reference set, which greatly improved overall performance. The approximate 40,000 phenotypes scored in these populations provide a path to determine empirically how the power to detect associations is affected by the imputation procedures. That is, at a fixed false discovery rate, the number of cis-eQTL discoveries detected by various methods can be interpreted as their relative statistical power in the GWAS. In this study, we find that imputation offer modest additional power (by 4%) on top of either Ilmn317K or Ilmn650Y, much less than the power gain from Ilmn317K to Ilmn650Y (13%). Conclusion Current algorithms can accurately impute genotypes for untyped markers, which enables researchers to pool data between studies conducted using different SNP sets. While genotyping itself results in a small error rate (e.g. 0.5%), imputing genotypes is surprisingly accurate. We found that dense marker sets (e.g. Ilmn650Y) outperform sparser ones (e.g. Ilmn317K) in terms of imputation yield and accuracy. We also noticed it was harder to impute genotypes for African American samples, partially due to population admixture, although using a pooled reference boosts performance. Interestingly, GWAS carried out using imputed genotypes only slightly increased power on top of assayed SNPs. The reason is likely due to adding more markers via imputation only results in modest gain in genetic coverage, but worsens the multiple testing penalties. Furthermore, cis-eQTL mapping using dense SNP set derived from imputation achieves great resolution, and locate associate peak closer to causal variants than conventional approach.

Imputed Genotypes Versus Sequenced Genotypes for the Association Analysis of Rare Variants

Performance of Genotype Imputation for Rare Variants Identified in Exons and Flanking Regions of Genes

Integrative Analysis of Sequencing and Array Genotype Data for Discovering Disease Associations with Rare Mutations

Systematic single-variant and gene-based association testing of thousands of phenotypes in 394,841 UK Biobank exomes

Rare variant contribution to human disease in 281,104 UK Biobank exomes

Exome sequencing and analysis of 454,787 UK Biobank participants

Accuracy of genome-wide imputation of untyped markers and impacts on statistical power for association studies

Efficient Identification of Trait-Associated Loss-of-function Variants in the UK Biobank Cohort by Exome-Sequencing Based Genotype Imputation

Extending Rare-Variant Testing Strategies: Analysis of Noncoding Sequence and Imputed Genotypes

Performance of Genotype Imputation for Low Frequency and Rare Variants from the 1000 Genomes

Population structure analysis using rare and common functional variants

Yield of genetic association signals from genomes, exomes and imputation in the UK Biobank

Implication of Next-Generation Sequencing on Association Studies

Estimating Genetic Effects and Quantifying Missing Heritability Explained by Identified Rare-Variant Associations

Pooled Association Tests for Rare Genetic Variants: A Review and Some New Results

Impact of the inaccessible genome on genotype imputation and genome-wide association studies

Impact of genotyping errors on statistical power of association tests in genomic analyses: A case study.

Genetic associations of protein-coding variants in human disease

Investigation of recessive effects of coding variants on common clinical phenotypes in exome-sequenced UK Biobank participants

Meta-analysis of Gene-Level Tests for Rare Variant Association.

Methods for the Analysis and Interpretation for Rare Variants Associated with Complex Traits.